Neonatal Encephalopathy Clinical Trial
— POSTPARTUMOfficial title:
Evaluation of Cerebral, Hemodynamic and Neuronal Activities in Neonates in the Immediate Postpartum
Neonatal anoxia-ischemia causes significant neurodevelopmental disorders. In this study the investigators want to better understand the interactions between the nervous and the hemodynamic cerebral systems during the adaptation of the neonate to ectopic life just after birth. Birth is an at risk situation of neonatal anoxic ischemia and the lack of objective criteria for cerebral tissue oxygenation has consequences on neuronal activity. Ph cord analysis is inadequate and only indirectly reflects the state of cerebral oxygenation. Both neuronal and vascular systems are part of the same functional entity and the analysis of their interactions is likely to reveal some early malfunctions of these networks. In this study, the investigators want to develop a multi-scale, multimodal approach that allows simultaneous interrogation of both neuronal and vascular compartments during the 15 minutes after delivery. The investigators will record, with the aid of a single sensor placed on the scalp of the child, the electroencephalogram and the cerebral tissue oxygenation. The investigators will measure interactions by means of correlation analysis between both signals.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | January 2024 |
Est. primary completion date | January 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Minute to 15 Minutes |
Eligibility | Inclusion Criteria: - Full term neonates between 36 and 41 weeks Gestational Age Exclusion Criteria: - Premature neonates - Neonates of twin pregnancy - Suspicion of congenital malformation seen in antenatal ultrasound - Any pathology requiring pediatric care from birth - Newborns whose mothers had a chronic viral infection such as AIDS, hepatitis B or C, or who had a multidrug-resistant bacteria |
Country | Name | City | State |
---|---|---|---|
France | CHU Amiens | Amiens |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire, Amiens |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Temporal correlation with EEG | Within the 5 min after birth the electroencephalogram and the cerebral oxymetry of the neonates will be recorded with the aid of a patch on the scalp. A multimodal approach must be developed to interrogate the dynamics and interactions of neuronal and vascular compartments, which constitute a single functional unit. | within the 5 minutes after birth | |
Primary | time-frequency correlation with EEG | Within the 5 min after birth the electroencephalogram and the cerebral oxymetry of the neonates will be recorded with the aid of a patch on the scalp. A multimodal approach must be developed to interrogate the dynamics and interactions of neuronal and vascular compartments, which constitute a single functional unit. | within the 5 minutes after birth | |
Primary | temporal correlation with NIRS signals | Within the 5 min after birth the electroencephalogram and the cerebral oxymetry of the neonates will be recorded with the aid of a patch on the scalp. A multimodal approach must be developed to interrogate the dynamics and interactions of neuronal and vascular compartments, which constitute a single functional unit. | within the 5 minutes after birth | |
Primary | time-frequency correlation with NIRS signals | Within the 5 min after birth the electroencephalogram and the cerebral oxymetry of the neonates will be recorded with the aid of a patch on the scalp. A multimodal approach must be developed to interrogate the dynamics and interactions of neuronal and vascular compartments, which constitute a single functional unit. | within the 5 minutes after birth | |
Secondary | Mode of delivery correlation with temporal and EEG data | Within the 5 min after birth the electroencephalogram and the cerebral oxymetry of the neonates will be recorded with the aid of a patch on the scalp. | within the 5 minutes after birth |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05471336 -
Enteral Feeding and Splanchnic NIRS Values in Infants With Neonatal Encephalopathy (NE)
|
N/A | |
Recruiting |
NCT05514340 -
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
|
Phase 2 | |
Recruiting |
NCT04603547 -
Transcutaneous Carbon Dioxide Monitoring in Neonates Receiving Therapeutic Hypothermia for Neonatal Encephalopathy
|
||
Completed |
NCT01913340 -
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
|
Phase 1/Phase 2 | |
Completed |
NCT00581581 -
CoolCap Followup Study-Coordination of Participating Centers
|
N/A | |
Recruiting |
NCT05772416 -
Neonatal Neurological Examination to Detect Infants at Risk
|
||
Completed |
NCT03122808 -
Uterine Activity in Moderate-Severe Neonatal Encephalopathy: A Case Control Study
|
||
Recruiting |
NCT02544100 -
Neonatal Neurologic Intensive Care Network of China
|
||
Completed |
NCT03380013 -
OMT to Improve Feeding After Hypothermia
|
N/A | |
Active, not recruiting |
NCT03409770 -
Optimising the Duration of Cooling in Mild Encephalopathy
|
N/A | |
Recruiting |
NCT05127070 -
Evaluating the NeoTree in Malawi and Zimbabwe
|
||
Not yet recruiting |
NCT06098833 -
Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia
|
Phase 2 | |
Not yet recruiting |
NCT05756296 -
The Long-term Consequences of Neonatal Encephalopathy in the Hypothermia Era
|
||
Recruiting |
NCT04432662 -
Darbepoetin in Neonatal Encephalopathy Trial
|
Phase 2 | |
Recruiting |
NCT02793999 -
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
|
||
Not yet recruiting |
NCT05889507 -
Cooling in Mild Encephalopathy
|
N/A | |
Recruiting |
NCT05848271 -
Natural History Study of Patients With HPDL Mutations
|
||
Not yet recruiting |
NCT04176471 -
TIME Study: Therapeutic Hypothermia for Infants With Mild Encephalopathy
|
N/A | |
Completed |
NCT01309711 -
Magnetic Resonance Biomarkers in Neonatal Encephalopathy
|
||
Recruiting |
NCT05610085 -
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
|
Phase 2 |